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Tiotropium modulates transient receptor potential V1
(TRPV1) in airway sensory nerves: A beneficial off-target
effect?
Mark A. Birrell, PhD, Sara J. Bonvini, BSc, Eric Dubuis, PhD, Sarah A. Maher, PhD, Michael A. Wortley, PhD,
Megan S. Grace, PhD, Kristof Raemdonck, PhD, John J. Adcock, PhD, and Maria G. Belvisi, PhD London, United KingdomBackground: Recent studies have suggested that the long-acting
muscarinic receptor antagonist tiotropium, a drug widely
prescribed for its bronchodilator activity in patients with
chronic obstructive pulmonary disease and asthma, improves
symptoms and attenuates cough in preclinical and clinical
tussive agent challenge studies. The mechanism by which
tiotropium modifies tussive responses is not clear, but an
inhibition of vagal tone and a consequent reduction in mucus
production from submucosal glands and bronchodilation have
been proposed.
Objective: The aim of this study was to investigate whether
tiotropium can directly modulate airway sensory nerve activity
and thereby the cough reflex.
Methods: We used a conscious cough model in guinea pigs,
isolated vagal sensory nerve and isolated airway neuron tissue–
and cell-based assays, and in vivo single-fiber recording
electrophysiologic techniques.
Results: Inhaled tiotropium blocked cough and single C-fiber
firing in the guinea pig to the transient receptor potential (TRP)
V1 agonist capsaicin, a clinically relevant tussive stimulant.
Tiotropium and ipratropium, a structurally similar muscarinic
antagonist, inhibited capsaicin responses in isolated guinea pig
vagal tissue, but glycopyrrolate and atropine did not.
Tiotropium failed to modulate other TRP channel–mediated
responses. Complementary data were generated in airway-
specific primary ganglion neurons, demonstrating thatFrom Respiratory Pharmacology, National Heart and Lung Institute, Faculty of
Medicine, Imperial College London.
M.A.B., S.A.M., and M.S.G. were funded by project grants from the Medical Research
Council (MRCUK: G0800196; G0800195; MR/K020293/1). S.J.B. andM.A.W. were
supported by NHLI Trust and MRC studentships, respectively. E.D. was funded by a
Wellcome Trust project grant (089301/Z/09/Z) and latterly by a research grant from
Boehringer-Ingelheim. Consumables were funded by Boehringer-Ingelheim. The hu-
man tissue experiments in this study were undertaken with the support of the NIHR
Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield
NHS Foundation Trust and Imperial College London.
Disclosure of potential conflict of interest: M. G. Belvisi has received research support
from Boehringer Ingelheim; has received support for travel to the 2012 ERS meeting;
is a Director of IR Pharma CRO; has received consultancy fees fromChiesi, Glenmark,
Almirall, AstraZeneca, GlaxoSmithKline, SunPharma, Provesica, Ario, and Innos-
quared; and has received lecture fees from Chiesi. The rest of the authors declare
that they have no relevant conflicts of interest.
Received for publication September 24, 2013; revised November 22, 2013; accepted for
publication December 2, 2013.
Available online February 7, 2014.
Corresponding author: Maria G. Belvisi, PhD, Respiratory Pharmacology, National
Heart and Lung Institute, Faculty of Medicine, Imperial College London, Exhibition
Road, London SW7 2AZ, United Kingdom. E-mail: m.belvisi@imperial.ac.uk.
0091-6749
 2014 The Authors. Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.jaci.2013.12.003
Open access under CC BY license.tiotropium inhibited capsaicin-induced, but not TRPA1-
induced, calcium movement and voltage changes.
Conclusion: For the first time, we have shown that tiotropium
inhibits neuronal TRPV1-mediated effects through a
mechanism unrelated to its anticholinergic activity. We
speculate that some of the clinical benefit associated with taking
tiotropium (eg, in symptom control) could be explained through
this proposed mechanism of action. (J Allergy Clin Immunol
2014;133:679-87.)
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Inhaled muscarinic receptor antagonists are currently used as
bronchodilators for the management of asthma and chronic
obstructive pulmonary disease (COPD).1 Their efficacy is
believed to be based on the notion that they block increased vagal
tone (through increased parasympathetic cholinergic contractile
responses, acetylcholine release, and muscarinic receptor
activation on airway smooth muscle), which is thought to be the
major reversible component of airflow narrowing in patients
with COPD.2,3 Tiotropium was the first long-acting muscarinic
receptor antagonist (LAMA), reaching the market in 2002.4-6
Initially, tiotropium was prescribed for its bronchodilator effects
in human subjects, but more recent evidence suggests that it might
also be effective in improving patients’ quality of life, reducing
exacerbations, and increasing exercise capacity.7 Tiotropium
has also recently been shown to improve asthma symptoms and
lung function in patients with inadequately controlled asthma.8
Preclinical and clinical studies have also suggested that
tiotropium inhibits cough in tussive challenge models.9,10
Dicipinigiatis et al10 reported that tiotropium inhibits capsaicin
(transient receptor potential [TRP] V1 agonist)–induced cough
in patients with upper respiratory tract infections (URIs) in a
prospective, randomized, double-blind, placebo-controlled
clinical trial. Bouyssou et al9 reported that tiotropium caused a
dose-dependent inhibition of citric acid–induced cough in a
guinea pig asthma model. An antitussive action of tiotropium in
acute challenge models through its antimuscarinic activity is
difficult to conceive. Various explanations have been proffered,
including inhibition of vagal tone (and thereby mucus secretion
and bronchodilation) elicited through blockade of muscarinic
M3 receptors on submucosal glands and airway smooth muscle,
respectively. However, the mechanism behind the antitussive
activity has never been fully elucidated.
The aim of this study was to investigate whether tiotropium can
directly modulate airway sensory nerves and thereby tussive
responses by using a range of techniques. We used an isolated
vagus nerve preparation and calcium imaging of primary sensory
jugular neurons to circumvent the potentially confounding679
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of tiotropium, which are presumably associated with its
antimuscarinic activity, and to avoid the pharmacokinetic and
numerous other considerations that limit the interpretation of
in vivo data. The ability to use human vagus nerve preparations
also allowed us the opportunity to translate our findings to the
clinical setting. An inhibitory activity on capsaicin-induced
action potential firing in vivo confirmed an interaction of
tiotropium with TRPV1 on airway-specific C-fibers.
In summary, our data suggest that tiotropium inhibits TRPV1
ion channel activity through a mechanism unrelated to its
anticholinergic activity. This activity is not through a general
inhibition of sensory nerve activity because TRPA1-mediated
responses were not affected. In conclusion, we suggest that some
of the clinical benefit associated with taking tiotropium could be
explained through its inhibition of TRPV1 responses.METHODS
Effect of tiotropium on capsaicin-induced cough
To establish an effective dosing regimen, we first performed a
concentration response to inhaled tiotropium against methacholine
(MCh)–induced bronchospasm (as estimated by changes in enhanced pause
[Penh]). Conscious guinea pigs were exposed to either aerosolized vehicle
(0.5% ethanol in saline) or tiotropium (3, 10, or 30mg/mL; this equates to 6.35,
21.2, and 63.5 mmol/L solution) for 10 minutes and were challenged 50
minutes later with either saline or MCh (0.1 mg/mL). Changes in Penh were
recorded for 5 minutes. From these data, doses of tiotropium were selected to
be tested against capsaicin-induced cough, as previously described.11-14
Briefly, after exposure to vehicle or tiotropium solution as above, cough was
induced by exposing the guinea pigs to an aerosol of capsaicin (60 mmol/L)
for 5 minutes. See additional methods in the Methods section in this article’s
Online Repository at www.jacionline.org.Effect of tiotropium on isolated vagal sensory nerve
tissue
Guinea pigs were culled with an overdose of pentobarbitone (200 mg/kg
administered intraperitoneally). The 2 vagal trunks were carefully dissected
free and placed in Krebs-Henseleit solution. The segments of vagus nerve
were mounted in a grease-gap dual-recording chamber system, as previously
described, and depolarization (as an indicator of sensory nerve activity) of the
nerve was assessed.11-14 Briefly, tissue was exposed to pre-established
submaximal concentrations of the TRP agonist twice, treated with vehicle
or test compound, and then rechallenged with the TRP agonist. After a
wash step, the TRP agonist was reapplied. The effect of tiotropium wasinvestigated on depolarization induced by a range of TRPV1 agonists,
including capsaicin,13,15 and against depolarization induced by the TRPA1
agonist acrolein (300 mmol/L)12 and the TRPV4 agonist GSK1016790A
(0.3 mmol/L).16 Key experiments were repeated with human vagal tissue.
Ethical approval to use recipient human lung/vagal tissue (transplant tissue)
was obtained from the Royal Brompton & Harefield Trust (REC reference
09/H0708/72). See additional methods in the Methods section in this article’s
Online Repository.Effect of tiotropium on airway-specific ganglion
cells
Identification of airway-specific neurons was performed, as previously
described.17,18 Briefly, 14 days before the experiment, guinea pigs
were dosed intranasally with the lipophilic retrograde tracer dye DilC18(3)-
1,19-dioctacetyl-3,3,39,39-tetramethyl-indocarbocyanine perchlorate (DiI).
Guinea pigs were then killed, and the jugular ganglia were harvested to
measure calcium movement and membrane voltage change, as described
previously.13 DiI-labeled neurons from jugular ganglia were then stained
with both a ratiometric calcium-sensitive dye (Fura2-AM, 3 mmol/L) and a
voltage-sensitive dye (Di-8-ANEPPS). The focus was on jugular ganglion
cells because we have previously found these to be more responsive to
capsaicin under normal conditions compared with airway nodose ganglion
cells.13 The responsiveness and viability of neurons were assessed by means
of application of 50 mmol/L potassium chloride extracellular solution (K50)
at the start and end of recording. Intracellular calcium ([Ca21]i) responses
were recorded as the area under the curve, and membrane depolarization
responses were recorded as the peak magnitude. All responses were
normalized to the initial K50 application. See additional methods in the
Methods section in this article’s Online Repository.Effect of tiotropium on capsaicin-driven TRPV1
FLIPR assays (performed with GenScript)
HEK293 cells were geneticallymodified to overexpress humanTRPV1 and
seeded in a 384-well, black-wall, clear-bottom plate at a density of 20,000
cells per well in 20mL of medium. Cells were cultured for 18 hours before the
day of the experiment and maintained at 378C in 5% CO2. Capsaicin
concentration-response curves were performed to select a submaximal
concentration in HEK293 cells overexpressing human TRPV1. Calcium-4,
in conjunction with a Fluorescent Imaging Plate Reader, was used to record
the signal. Assays were performed in duplicate. See additional methods in
the Methods section in this article’s Online Repository.Effect of tiotropium on capsaicin-induced firing of
single-fiber afferents and bronchospasm
Guinea pigs were anesthetized with urethane (1.5 g/kg) intraperitoneally.
The trachea was cannulated, and bronchospasm was measured with an
air-pressure transducer connected to a side arm of the tracheal cannula.
Animals were paralyzed with vecuronium bromide, which was initially
administered at an intravenous dose of 0.10 mg/kg and followed every 20
minutes with 0.05 mg/kg administered intravenously to maintain paralysis.
Firing of single-fiber afferents and bronchospasmwasmeasured, as previously
described.19 Briefly, after the vagus nervewas dissected clear of tissue, a single
fiber was isolated and placed on the recording electrodes. After establishing it
was an airway C-fiber, the animal was challenged with inhaled capsaicin after
vehicle or inhaled test compound, and action potentials were recorded. See
additional methods in the Methods section in this article’s Online Repository.Effect of tiotropium on isolated guinea pig tracheal
contractions
Contractile responses to MCh or capsaicin were induced in isolated guinea
pig trachea by using a system previously described.20 Briefly, the trachea was
placed in oxygenated Krebs-Henseleit solution at 378C and exposed to
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contraction was assessed. See additional methods in the Methods section in
this article’s Online Repository.FIG 1. Effect of inhaled tiotropium on capsaicin-induced cough. Conscious
guinea pigs were exposed to an aerosol of vehicle (0.5% ethanol in saline)
or tiotropium (10 or 100 mg/mL) for 10 minutes. Fifty minutes later, the
guinea pigs were challenged with an aerosol of capsaicin (60 mmol/L) for
5 minutes. Cough was recorded during the 5-minute challenge and for a
further 5 minutes. Data are shown as means and SEMs (n 5 9). *P < .05 as
determined by Kruskall-Wallis with Dunn post hoc analysis.Data analysis and statistics
Inhibition of capsaicin-induced cough was analyzed by using the
nonparametric Kruskal-Wallis test with the Dunn post hoc test, comparing
drug group responses with those of the vehicle control group. Data are
presented as medians 6 interquartile ranges. In the in vivo single-fiber
experiments, inhibition was determined by using a 2-tailed paired Student
t test, comparing responses to agonist (in the same fiber) in the presence and
absence of vehicle/antagonist. Inhibition of agonist-induced vagus nerve
depolarization was analyzed by using the 2-tailed paired Student t test,
comparing responses to agonist (in the same piece of vagus nerve) in the
absence and presence of vehicle/antagonist. For imaging, all responses in
each cell were normalized to the initial response generated by application of
K50 within the same cell. Data were analyzed for ‘‘responding’’ cells only
and defined as a neuron with a response of 10% or greater of K50. Inhibition
of responses was analyzed by using the 2-tailed Student paired t test,
comparing responses to agonist (in the same cell) in the absence and presence
of vehicle/antagonist. Data are presented as means6 SEMs. For all statistical
analyses, a P value of less than .05 was considered significant.RESULTS
Effect of tiotropium on capsaicin-induced cough
Aerosolized tiotropium caused a dose-related blockade
of MCh-induced change in Penh (a noninvasive surrogate
measurement of bronchoconstriction) in the conscious guinea
pig (see Fig E1 in this article’s Online Repository at www.
jacionline.org). From these data, we selected the lowest effective
dose of tiotropium (10 mg/mL z 21.2 mmol/L) and a log-fold
higher dose (because we did not know the potency and
pharmacokinetic profile of tiotropium against the sensory nerve
target) to test against capsaicin-induced cough. Tiotropium
caused a significant inhibition of capsaicin-induced cough (Fig 1).Effect of tiotropium on isolated vagal sensory nerve
tissue
Tiotropium and a structurally similar muscarinic antagonist,
ipratropium, caused a concentration-dependent inhibition of
capsaicin-induced depolarization in the isolated guinea pig vagus
nerve (Fig 2, A and B). This inhibition was also seen in the rat
isolated vagus nerve, where tiotropium (1 nmol/L) inhibited
capsaicin-induced depolarization. However, tiotropium did not
cause any inhibition of capsaicin responses in the mouse vagus
nerve (see Fig E2 in this article’s Online Repository at www.
jacionline.org). To demonstrate that the effect of tiotropium was
not specific to capsaicin-induced activation of TRPV1, we showed
that it modulated a second TRPV1 selective agonist,
resiniferatoxin (RTX), as well as prostaglandin E2 (PGE2),
which is known to act partially through the TRPV1 channel (Fig
2, C).13 Interestingly, other muscarinic receptor antagonists (gly-
copyrrolate and atropine) did not inhibit capsaicin responses (Fig
2, D). Tiotropium and ipratropium did not modulate TRPA1 or
TRPV4 agonist–induced depolarization of guinea pig vagus. In
these experiments the specific TRPA1 and TRPV4 antagonists
HC-030031 and HC-067047, respectively (10 mmol/L), were
used as positive controls (Fig 2, E and F). MCh caused a
concentration-related contraction of guinea pig tracheal
tissue but did not induce depolarization of the vagal tissue(see Fig E3 in this article’s Online Repository at www.
jacionline.org). Both tiotropium and ipratropium attenuated
capsaicin-induced, but not acrolein-induced, depolarization of hu-
man vagal tissue, whereas glycopyrrolate was ineffective (Fig 3).Effect of tiotropium on changes in [Ca21]i and
membrane voltage in primary guinea pig sensory
jugular neurons
Although the vagus system has many benefits, one issue is that
some of the sensory nerves contained in the trunk will innervate
other nonlung organs, and thus the data obtained might not be
indicative of airway-specific fibers. To address this, we harvested
airway-specific primary ganglion neurons (stained with Dil;
Fig 4, A) and assessed changes in [Ca21]i levels and membrane
voltage. Tiotropium inhibited TRPV1-driven (Figs 4, B, and 5,
A and B), but not TRPA1-driven, responses (Figs 4, C, and 5, E
and F). Glycopyrrolate did not modulate capsaicin-induced
increases in [Ca21]i levels or membrane voltage (Fig 5, C and
D). Similar to the data generated in the isolated vagus, MCh did
not trigger calcium movement or voltage changes in primary
airway jugular neurons (see Fig E4 in this article’s Online
Repository at www.jacionline.org). Concentration responses to
MCh on cells from the nodose ganglia were also performed to
ensure thatMCh does not activate other nerve fibers that innervate
the airways. However, there was no effect on either the calcium
signal or membrane depolarization at any concentration of MCh
(data not shown). In general, a 10-fold lower concentration of
test agents was required to reach the required response in these
experiments compared with those on the vagal trunk.Effect of tiotropium on capsaicin-driven TRPV1
FLIPR assays (GenScript)
To determine whether tiotropium was modulating TRPV1
function by acting as a classic receptor/ion channel antagonist, it
was evaluated in a GenScript FLIPR assay. JNJ-17203212
(TRPV1 positive control), tiotropium, and glycopyrrolate
were profiled against a submaximal concentration of capsaicin
FIG 2. Effect of muscarinic antagonists on depolarization of isolated guinea pig vagus nerve. A and
B, Concentration response data testing tiotropium and ipratropium against capsaicin (1 mmol/L)–induced
depolarization. C, Effect of tiotropium (1 nmol/L) against a range of TRPV1 agonists (capsaicin, 1 mmol/L;
RTX, 3 nmol/L PGE2, 10 mmol/L). D, Glycopyrrolate (10 nmol/L) and atropine (1 mmol/L) were tested against
capsaicin responses. E and F, Tiotropium (1 nmol/L) and ipratropium (10 nmol/L) were profiled against
acrolein (TRPA1 agonist, 300 mmol/L)–induced depolarization, with HC-030031 (TRPA1 antagonist,
10 mmol/L) as a positive control (Fig 2, E), and tiotropium was also profiled against GSK1016790a
(TRPV4 agonist, 300 nmol/L)–induced depolarization, with HC-067047 (TRPV4 antagonist, 10 mmol/L) as a
positive control (Fig 2, F). Data are shown as means 6 SEMs of the percentage inhibition of tussive
agent–induced depolarization (n 5 4-6).
FIG 3. Effect of muscarinic antagonists on depolarization of isolated human
vagus. A, Example trace from human vagal tissue. B, Inhibitory effect of
tiotropium (1 nmol/L), ipratropium (10 nmol/L), and glycopyrrolate
(10 nmol/L) when tested against capsaicin (1 mmol/L)– and acrolein (300
mmol/L)–induced depolarization. Data are shown as means 6 SEMs of the
percentage inhibition of tussive agent–induced depolarization (n 5 2-3).
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in this article’s Online Repository at www.jacionline.org).
JNJ-17203212 inhibited the capsaicin-induced signal in aconcentration-dependent manner in HEK293 cells (see Fig E5,
B); however, the other compounds did not significantly inhibit
the signal under these assay conditions (see Fig E5, C and D).Effect of tiotropium on C-fiber activation by
capsaicin in vivo
Inhaled capsaicin (100 mmol/L) administered by means of
aerosol for 15 seconds induced a burst of C-fiber firing and
bronchospasm in anaesthetized guinea pigs (Fig 6). Fig 6, A,
shows an example trace; the top panel illustrates changes in
airway pressure (bronchospasm), and the bottom panel is the
simultaneous measurement of airway nerve single C-fiber firing.
Fig 6, B, depicts the average change in airway pressure after the
various treatments; Fig 6, C, depicts the average peak frequency
of impulses per second; and Fig 6, D, depicts the total impulses
counted over the time recorded from a single C-fiber afferent
treated with capsaicin. Pretreatment with tiotropium (100 mg/
mL z 212 mmol/L) reduced capsaicin-induced firing to a level
not significantly different from spontaneous firing (an example
is shown in the bottom trace of the far right part of Fig 6, A;
and averages are shown in Fig 6, C and D). Interestingly, the in-
crease in airway pressure did not appear to be altered (Fig 6, B).Effect of tiotropium on capsaicin-induced
contractions of isolated guinea pig trachea
MCh and capsaicin caused contraction of the isolated
guinea pig trachea (see Fig E6 in this article’s Online Repository
FIG 4. Effect of tiotropium on capsaicin- and acrolein-induced [Ca21]i in primary airway guinea pig ganglion
cells. Airway-specific neurons were chosen by using the Dil stain as a marker; an example is shown in (A).
Neurons were challenged with K50 for a reference response and then exposed to 2 challenges of either
capsaicin (Caps, 0.1 mmol/L) or acrolein (Acro, 10 mmol/L). The cells were then exposed to 0.1 nmol/L
tiotropium for 20 minutes, after which the cells were rechallenged with the respective challenge agent.
After a wash step, the cells were challenged with the tussive agent. B and C, Example traces were obtained:
open triangles indicate K50 challenge, and solid triangles show where the challenge agent was added.
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related inhibition of MCh responses (see Fig E6, A) but did not
affect capsaicin-induced contractions (see Fig E6, B). The
positive control JNJ-17203212 (100 mmol/L) blocked capsaicin
responses (data not shown).DISCUSSION
Bronchodilators provide the main pharmacologic intervention
used in the treatment of COPD and are often used in the treatment
of asthma. Anticholinergic agents appear to be the most effective
therapy used to combat increases in airway bronchomotor tone.2
There are currently 2 anticholinergic agents available for the
treatment of COPD: the short-acting drug ipratropium bromide
and the LAMA tiotropium. However, some of the clinical benefit
associated with taking these compounds (eg, the antitussive
activity10) cannot easily be explained by their proposed mecha-
nism of action as muscarinic receptor antagonists. In addition to
bronchodilation, tiotropium and ipratropium have been shown
to inhibit capsaicin-induced cough in animal models21 and in
patients with URIs10,22 and asthma.23 Ipratropium has also beenfound to inhibit cough induced by ultrasonically nebulized
distilled water in both healthy and asthmatic subjects.24 Further-
more, a systematic review of the literature assessing all trials in
adult patients with respiratory and nonrespiratory diseases
(excluding those with cancer who had chronic cough as a
secondary or primary outcome) suggested that ipratropium
possesses antitussive properties.25 These studies aimed to
investigate the mechanism of action behind the inhibitory activity
on sensory nerve activity and cough.
In these studies we have presented conclusive data that suggest,
for the first time, that tiotropium inhibits TRPV1-mediated effects
through a mechanism unrelated to its anticholinergic activity.
Tiotropium significantly attenuated capsaicin-evoked cough at
similar doses to that required to block MCh-driven broncho-
spasm, suggesting that this additional activity of tiotropium
occurs at clinically relevant doses. Further evidence pointing to
an interaction with the TRPV1 ion channel comes from data
demonstrating an inhibitory activity on capsaicin-induced
depolarization of guinea pig, rat, and human vagus nerve tissues.
The lack of effect in mouse tissue indicates a likely species
difference in the interaction of tiotropium with the TRPV1 ion
FIG 5. Effect of tiotropium and glycopyrrolate on capsaicin- and acrolein-stimulated primary airway guinea
pig ganglion cells. A and B, Percentage inhibition caused by tiotropium of the calcium levels and voltage
changes after capsaicin (0.1 mmol/L) challenge. C and D, Data from testing glycopyrrolate against capsaicin
(0.1 mmol/L) challenge. E and F, Data from testing tiotropium against acrolein (10 mmol/L) responses. Data
are shown as means 6 SEMs of the percentage inhibition of tussive agent–induced depolarization (n 5 4).
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demonstrating an inhibitory activity of tiotropium on capsaicin-
induced calcium influx and membrane voltage in primary jugular
ganglion cells and action potentials in single airway C-fibers,
as assessed in vivo, indicates an interaction with TRPV1 ion
channels on airway-specific C-fibers.
Although the in vivo data obtained in the conscious cough
model strongly suggest that tiotropium can modulate TRPV1
airway responses, it could be argued that the inhibition seen
in vivo could occur through an effect on vagally mediated,
muscarinic agonist–driven changes in airway tone, mucus
production, or both. To avoid issues with data interpretation
associated with in vivo studies, we used the isolated vagus nerve
preparation to probe mechanistic questions in greater detail. This
preparation allowed us to show that tiotropium inhibits sensory
nerve depolarization induced by other stimuli known to activatesensory nerves totally or partially through TRPV1 (ie, RTX15
and the endogenous mediator PGE2).
13 This general inhibitory
activity on TRPV1-mediated activation of vagal afferents,
irrespective of the ligand used, would suggest that these effects
are not specific to capsaicin and further support an interaction
with TRPV1. The similar inhibitory effect of the structurally
similar ipratropium26 and the lack of an inhibitory effect with
atropine or a second LAMA, glycopyrrolate,27-29 suggest that
modulation of TRPV1 is particular to certain antagonists rather
than through their common mechanism of action of muscarinic
receptor antagonism. The lack of inhibitory activity of atropine
and glycopyrrolate on capsaicin–induced vagal depolarization
is in contrast to data suggesting that these compounds can inhibit
capsaicin-induced cough in animal models30-32 and in a limited
data set showing this activity in a clinical healthy volunteer
study.33 This might suggest that it is indeed the anticholinergic
FIG 6. Effect of tiotropium on capsaicin-induced bronchospasm and firing of airway-specific sensory
afferent nerves. A, Example of recording of bronchospasm (top trace) and simultaneous vagus nerve single
C-fiber firing (bottom trace). Capsaicin (100 mmol/L) was administered by means of aerosol for 15 seconds
and indicated by arrows below the traces. Saline (0.9% for 1 minute) and tiotropium (100 mg/mL for 1
minute) administration are indicated below the traces by arrows. Voltage and pressure scales are indicated
by bars on the left of the traces, and the time scale is provided by a 60-second black bar between the traces.
B-D, Histograms represent the average changes in airway pressure induced by capsaicin before and after
tiotropium (Fig 6, B), the average peak frequency of impulses per second recorded from vagus nerve single
C-fiber capsaicin-induced firing before and after tiotropium (Fig 6, C), and the average total impulse count
over time (5-minute window from nebulization) recorded from vagus nerve single C-fiber capsaicin-induced
firing before and after tiotropium (Fig 6, D). Data are shown asmeans6 SEMs (n5 3). *P < .05 and **P < .01
as determined by Mann-Whitney U test.
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favored explanation in light of these data that any inhibitory
action observed on tussive responses is mediated through
alternative mechanisms.
Further evidence to suggest that the activity of tiotropium on
sensory afferents is not through its activity at muscarinic receptors
comes from the fact that an exogenous muscarinic agonist failed
to cause depolarization of the vagal tissue. We were also able to
demonstrate that the activity of tiotropium appears to be specific
for TRPV1-driven responses because it does not modulate the
depolarization evoked by TRPA1 or TRPV4 agonists. Finally, we
were able to test the hypothesis in vagal tissue harvested
from human donor tissue surplus to transplant requirement.
Depolarization of the isolated human vagus has previously been
shown to be similar to that seen in guinea pigs and predictive
of cough.11-14 The inhibitory activity of tiotropium on capsaicin-
induced depolarization in this assay provides translational data
that support our hypothesis.
In parallel, many of our key findings in isolated vagus nerves
were duplicated in isolated primary jugular airway ganglion
neurons. This system has the added benefit of being able to
identify and study airway-specific nerve cells. This is important
given the vagal trunk contains nerves connected to an array ofinternal organs. The data obtained showed that tiotropium, but not
another LAMA, glycopyrrolate, was a potentmodulator of TRPV1
(capsaicin)–induced but not TRPA1 (acrolein)–induced changes in
calcium andmembranevoltage. Furthermore,MCh did not change
calcium levels or membrane voltage in airway sensory neurons,
which is consistent with the theory that tiotropium is not behaving
as a classical muscarinic receptor antagonist in this context.
Interestingly, tiotropium did not significantly inhibit increases in
calcium levels evoked by capsaicin in a commercial FLIPR assay
(approximately 20% reduction in the peak signal, GenScript). It
was not immediately clear why there was a discrepancy between
data generated in our primary cell and tissue assays and that
generated in a configured system using a cell line that is genetically
altered to overexpress human TRPV1 channels. However, the
positive control (JNJ-17203212), a well-known TRPV1 antago-
nist,34 performed as one would expect. Indeed, the data obtained
were very similar to those we have published previously using
the isolated vagal system, both in respect to potency and efficacy.13
Thus we suggest that tiotropium does not act as a ‘‘typical’’ TRPV1
antagonist and acts either by interacting with another binding site
on the channel or by acting indirectly as a modulator of the
TRPV1 channel. Further evidence for this ‘‘nontypical’’ interaction
is the apparent lack of effect of tiotropium on capsaicin-induced
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induced in the in vivo single-fiber recording model in which tio-
tropium reduced capsaicin-induced afferent fiber firing without
modulating the changes in bronchospasm. The contraction/bron-
chospasm observed in these 2 systems is thought to be through
capsaicin acting on TRPV1 channels on nerves and causing the
local release of substance P, which then acts on neurokinin recep-
tors on the airway smooth muscle causing it to contract.35,36
A classical TRPV1 antagonistwould be expected tomodulate these
responses; indeed, here we have shown that JNJ-17203212 inhibits
capsaicin-induced contraction in guinea pig airways. Identifying
this off-target but beneficial action of tiotropium on sensory nerve
activation could open up other therapeutic areas for this compound,
including the treatment of cough and the sensory hyperresponsive-
ness phenotype, which might be involved in dyspnea, the late asth-
matic response, and airway hyperresponsiveness.37-39
Interestingly, the use of tiotropium in patients has not been
associated with the unwanted side effects associated with TRPV1
antagonists (ie, hyperthermia).40 The fact that it is not a classical
antagonist could explain why no one has observed these effects.
Other explanations could be that the route of administration
(ie, topical) and dosing regimen (ie, once a day) could reduce
the thermal effects. Another possibility could be that tiotropium
has a selectivity profile similar to that of many of the TRPV1
antagonists recently described that are not reported to have effects
on temperature control41-44 or because the change in thermal
control has been very transient, as has recently been observed
in a phase 1 clinical trial with a new TRPV1 antagonist.45
In conclusion, for the first time, we have shown that tiotropium
inhibits TRPV1-mediated effects through a mechanism unrelated
to its anticholinergic activity. The activity of tiotropium on
TRPV1 might be responsible, at least in part, for some of the
clinical benefit associated with taking it and might suggest
alternative applications for this compound outside of COPD in
respiratory and nonrespiratory disorders in which cough is a
major debilitating symptom. Several other LAMAs (eg, aclidi-
nium bromide46) are currently in clinical development, and it
remains to be seen whether these compounds share the same
beneficial properties.
Key messages
d Recent studies have suggested that the LAMA tiotropium,
a drug widely prescribed for its bronchodilator activity in
patients with COPD and asthma, improves symptoms and
attenuates capsaicin-induced cough in preclinical and
clinical challenge studies.
d For the first time, we have demonstrated that tiotropium
inhibits TRPV1-mediated effects in sensory afferents
through a mechanism unrelated to its anticholinergic
activity.
d We suggest that some of the clinical benefit associated
with taking tiotropium could be explained through this
proposed mechanism of action.
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Effect of tiotropium on capsaicin-induced cough
To establish an effective dosing regimen, we first performed a
concentration response to inhaled tiotropium against MCh (muscarinic
receptor agonist)–induced bronchospasm. Conscious male Dunkin-Hartley
guinea pigs (350-450 g; Harlan, Bicester, United Kingdom) were placed in an
acrylic glass chamber and exposed to either aerosolized vehicle (0.5% ethanol
in saline) or tiotropium (3, 10, or 30mg/mL; this equates to 6.35, 21.2, and 63.5
mmol/L solution; Boehringer Ingelheim, Ingelheim,Germany) for 10minutes.
Fifty minutes later, the guinea pigs were placed in the same chambers used to
record cough and challengedwith either vehicle (saline) or a submaximal dose
of inhaled MCh (0.1 mg/mL). We estimate that over the 10 minutes of
challenge, the lungs will be exposed to approximately 0.28 to 2.8 mg of
tiotropium (based on a breathing rate of 80 breaths/min, a tidal volume of 3.5
mL, and a deposition rate of 10% with the aerosolized 10 mg/mL solution,
which is ‘‘diluted’’ 1,000- to 10,000-fold with room air from the nebulizer
system). Changes in Penh (an estimate of bronchospasm) were recorded for 5
minutes. From these data, doses of tiotropium were selected to be tested
against capsaicin-induced cough. Another set of guinea pigs was dosed (as
above) with vehicle (saline) or tiotropium (10 or 100 mg/mL) 60 minutes
before exposure to aerosolized capsaicin (60 mmol/L) for 5 minutes. The
number of coughs was recorded during aerosol challenge and for 5 minutes
after challenge and confirmed by a trained observer blinded to prior treatment,
as previously described.E1-E3 Experiments were approved by the Imperial Col-
lege London ethical review process committee, and procedures strictly
adhered to the Animals (Scientific Procedures) Act 1986 UK Home Office
guidelines. Experiments were performed under a Home office project license
(PPL 70/7212).
Effect of tiotropium on isolated vagal sensory nerve
tissue
This preparation has previously been characterized and shown to respond to
a range of agents known to cause cough both in preclinical models and
in human cough studies and provides the opportunity to conduct a compre-
hensive pharmacologic assessment of the direct action of drugs on the vagus
nerve without the pharmacokinetic and numerous other considerations that
limit the interpretation of in vivo data.E1-E3 In addition, the isolated sensory
nerve system allows us to perform parallel experiments with human tissue,
thus generating translational data.E4 Vagal tissue was harvested from male
Dunkin-Hartley guinea pigs, male Brown Norway rats, or male C57/Bl6
mice or through donor human lung tissue acquired through the International
Institute for the Advancement of Medicine (Edison, NJ; consent given for
scientific research), and experiments were conducted, as previously described.
Human tissuewas obtained from5 donors (4male subjects age 36-57 years and
1 female subject age 45 years) who had no known respiratory disease.
The effect of tiotropium was investigated on depolarization induced by a
range of TRPV1 agonists, including capsaicin (1 mmol/L), RTX (3 nmol/L),
and PGE2 (10 mmol/L), which is an endogenous mediator known to work
partially through TRPV1.E3,E5 Other muscarinic receptor antagonists were
also profiled against capsaicin-induced depolarization, including ipratropium,
atropine, and the LAMA glycopyrrolate.E6-E8
Tiotropium was tested against depolarization induced by the TRPA1
agonist acrolein (300 mmol/L)E2 and the TRPV4 agonist GSK1016790A (0.3
mmol/L) to determinewhether the effect of tiotropiumwas specific to TRPV1-
induced responses or whether it had a general effect on sensory nerves.E9 Key
experiments were repeated with human vagal tissue. To further investigate
whether the effect of tiotropium was through its anticholinergic activity, we
determined whether exogenous MCh would depolarize the vagal preparation.
We selected appropriate concentrations of MCh using an isolated guinea pig
tracheal system to assess contraction, as previously described.E10
Effect of tiotropium on airway-specific ganglion
cells
Identification of airway-specific neurons was performed, as previously
described.E11,E12 Briefly, 14 days before the experiment, guinea pigs weredosed intranasally with the lipophilic retrograde tracer dye DiI (1 mL/kg of
625 mg/mL; see compounds and materials). Guinea pigs were then killed,
and the jugular ganglia were harvested to measure calcium movement and
membrane voltage change, as described previously.E3 Ganglia were
predigested with collagenase/Dispase II at 378C. Ganglia were then digested
with papain for 30 minutes with gentle agitation at 378C and collagenase
IV/Dispase II for 40 minutes at 378C. The cells were then separated and placed
onto laminin-coated plates and flooded with complete F12 media after
adherence. DiI-labeled neurons from the jugular ganglia were then stained
with both a ratiometric calcium-sensitive dye (Fura2-AM, 3 mmol/L) and a
voltage-sensitive dye (Di-8-ANEPPS). Responsiveness and viability of
neurons were assessed by means of application of K50 at the start and end
of recording. [Ca21]i responses were recorded as the area under the curve,
andmembrane depolarization responses were recorded as the peakmagnitude.
All responses were normalized to the initial K50 application so that one could
account for differences between individual cell responses. Tiotropium and
glycopyrrolate were evaluated against capsaicin (0.1 mmol/L)–induced and
acrolein (10 mmol/L)–induced responses. In addition, we evaluated the effect
of MCh on [Ca21]i levels and voltage changes.
Effect of tiotropium on capsaicin-driven TRPV1
FLIPR assays (performed with GenScript)
HEK293 cells genetically modified to overexpress human TRPV1 were
seeded in a 384-well, black-wall, clear-bottom plate at a density of
20,000 cells per well in 20 mL of medium. Cells were cultured for 18 hours
before the day of the experiment andmaintained at 378Cand 5%CO2. Capsaicin
concentration-response curves were performed to select a submaximal
concentration. Calcium-4 in conjunction with a Fluorescent Imaging Plate
Reader was used to record the signal. Vehicle, tiotropium, glycopyrrolate, or
the positive control JNJ-17203212 (TRPV1 antagonistE3,E13) were added to
the well and incubated at 378C for 60 minutes before the addition of
capsaicin (10 nmol/L). Assays were performed in duplicate.
Effect of tiotropium on capsaicin-induced firing of
single-fiber afferents and bronchospasm
Guinea pigs were anesthetized with urethane (1.5 g/kg) intraperitoneally. If
required, anesthesia was supplemented with additional urethane. The trachea
was cannulated, and bronchospasm was measured with an air-pressure trans-
ducer (SenSym 647, Farnell, United Kingdom) connected to a side arm of the
tracheal cannula. Blood gases and pH were maintained at physiologic levels by
means of artificial ventilation (Ugo Basile small-animal ventilator, Varese,
Italy), with a tidal volume of 10 mL/kg and 50 to 60 breaths per minute of
laboratory air. The right jugular vein and carotid artery were cannulated for
injecting drugs and measuring systemic arterial blood pressure (Gould P23XL
transducer, Redruth, United Kingdom), respectively. Body temperature was
continuously monitored with a rectal thermometer and maintained at 378Cwith
a heated blanket and control unit (Harvard Apparatus, Holliston, Mass).
Animals were paralyzed with vecuronium bromide that was initially adminis-
tered at a dose of 0.10 mg/kg intravenously and followed every 20 minutes with
0.05 mg/kg administered intravenously to maintain paralysis. The depth of
anesthesia was frequently assessed bymonitoring the response of heart rate and
blood pressure to noxious stimuli. Both cervical vagus nerves were located
through a cervical incision and dissected free from the carotid artery and
sympathetic and aortic nerves; both vagus nerves were cut at the central end,
posterior to the vagal ganglia. The left vagus nerve was used for sensory nerve
fiber recording andwas cleared of its surrounding fascia. The skin andmuscle in
the neck at either side of the incisionwere lifted and tied to ametal ring to forma
well, which was filled with light mineral oil. Bipolar Teflon-coated platinum
electrodes (exposed at the tips) were used for recording purposes by using fascia
positioned on one electrode for a reference. The vagus nerve was placed on a
small black acrylic glass plate to facilitate subsequent dissection. Thin filaments
of nerve were teased from the vagus nerve under a binocular microscope
and placed on the second electrode until a single active unit or 1 of notmore than
2 or 3 units was obtained. Action potentials were recorded in a conventional
manner by using electrodes connected to a pre-amp headstage (Digitimer
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(x5000, Digitimer NL104), filtered (LF30Hz-HF8.5kHz, Digitimer NL125),
and passed through a Humbug noise reducer (AutoMate Scientific, Berkeley,
Calif) before input sampling and recording. All signals were sampled (50 kHz)
and recorded with the Spike 2 software data acquisition system through a CED
Micro1401 interface (Cambridge Electronics Design, Cambridge, United
Kingdom). The software allowed pulse train counting over selected time
periods. In addition, monitoring of the input signal to the Spike software was
also carried out on a digital storage oscilloscope (Tektronix DPO 2012,
Bracknell, United Kingdom). The input signal was also fed through an audio
amplifier to a loudspeaker. All animals were killed at the end of the experiments
with an overdose of pentobarbitone.
Conduction velocities were measured to distinguish slow-conducting
nonmyelinated C-fibers from fast-conducting myelinated A-fibers by
stimulating the vagus nerve close to the thorax with bipolar silver electrodes
using a suprathreshold voltage at 0.5 ms and 1 Hz (Grass stimulator,
Warwick, RI). The corresponding action potential was recorded in the nerve
fiber under observation. The stimulus and the recorded action potential were
captured on the Spike software in a single sweep, and the time interval
between them was measured to calculate the velocity by using the distance
from the cathode-stimulating electrode and the recording electrode. Aerosols
were generated by an Aerogen nebulizer (Buxco Nebulizer Control,
Wantage, United Kingdom) connected to the ventilator and arranged so
that the inspired air passed through the medication chamber before entering
the lungs of anesthetized animals through the tracheal cannula. Single vagus
nerve fibers were identified as originating from the 3 groups of airway
sensory nerve endings (ie, slowly adapting stretch receptors, irritant receptors
[rapidly adapting stretch receptors, RARs, Ad-fibers], and pulmonary/
bronchial C-fiber receptors) by using several criteria.E14 These included
pattern of spontaneous discharge, response to hyperinflation and deflation,
adaptation indices, and response to capsaicin aerosol administration and con-
duction velocities. As a rule, a fiber that had no obvious pattern to the spon-
taneous activity (often very sparse), did not respond to hyperinflation or
hyperdeflation, and responded to capsaicin aerosol was considered for further
investigation. Finally, verification of a C-fiber was confirmed at the end of the
experiment by determining conduction velocity. After surgery, the animals
were allowed to stabilize for at least 30 minutes. After identification of a
lung afferent fiber and its sensitivity to capsaicin aerosol, the following pro-
tocol was pursued: after a control baseline recording of at least 2 minutes,
capsaicin (100 mmol/L) was administered by means of aerosol for 15 sec-
onds, and the changes in fiber activity, intratracheal pressure, and blood
pressure were continuously recorded until baseline or a steady state was
re-established. After an interval of 10 minutes, saline (aerosol for 60 sec-
onds) was administered while recording variables. After another interval of
10 minutes, the capsaicin aerosol was repeated. Ten minutes later, tiotropium
(100 mg/mL for 60 seconds) was administered by means of aerosol, followed
30 minutes later by the capsaicin aerosol.
Effect of tiotropium on isolated guinea pig tracheal
contractions
Contractile responses to MCh or capsaicin were induced in isolated guinea
pig trachea by using a system previously described by Buckley et al.E10 The
effect of tiotropium was determined against MCh and capsaicin; the TRPV1
antagonist JNJ-17203212 (100 mmol/L)E13 was included as a positive control
in the capsaicin experiments.
Pharmacologic agents, such as the anesthetics used in the animal
experiments (eg, pentobarbitone, urethane, and vecuronium bromide) and
any of the drugs transplant donors had been taking before organ harvesting,
could be affecting sensory nerve responses in these systems. However, we are
confident that they would not complicate interpretation of the data with
tiotropium because we have time-matched, vehicle-treated control responses
that will also have been influenced by such agents. Furthermore, we believe
that as the ganglion cells are harvested through a complex multistep
extraction process and the isolated vagal preparation is constantly perfused,
any anesthetic agents, for example, will be removed before the start of
assessment.Compounds and materials
In vivo cough experiments. Capsaicin (Sigma, Dorset, United
Kingdom)was prepared as a 10mmol/L stockmade in ethanol andwas diluted
in vehicle to obtain a concentration of 60 mmol/L with 1% ethanol and 1%
Tween 80 in 0.9% saline. Tiotropium (Boehringer Ingelheim) was prepared at
concentrations of 10, 30, or 100 mg/mL with 0.5% ethanol in 0.9% saline.
MCh was prepared in 0.9% saline.
In vivo single-fiber experiments. Capsaicin (Sigma-Aldrich)
was dissolved in 1% ethanol and 1% Tween 80 in 0.9% saline to working
solution. Tiotropium (Boehringer Ingelheim) was dissolved in 0.9% saline.
Vecuronium bromide (Sigma-Aldrich) was dissolved in distilled water at 2.5
mg ∙ mL21 stock and diluted in distilled H2O, as required.
In vivo staining of airways neurons. The lipophilic
retrograde tracer dye DiI (Invitrogen, Carlsbad, Calif) was prepared as a
stock of 25 mg/mL diluted in 100% ethanol and kept in the dark at room
temperature. On the day of staining, the dye was diluted in 0.9% sterile saline
at a concentration of 625 mg/mL. A dose of 1 mL/kg was used for staining.
In vitro experiments. Capsaicin, RTX, MCh, glycopyrrolate,
atropine, acrolein, GSK1016790a, and ipratropium were purchased from
Sigma-Aldrich. PGE2 was purchased from Cayman Chemical (Ann Arbor,
Mich). HC-030031 was purchased from Chembridge (San Diego, Calif),
and HC-067047 was purchased from Peakdale Molecular Ltd (High Peak,
United Kingdom). Tiotropium was a gift from Boehringer Ingelheim
(Germany), and JNJ-17203212 was a gift from GlaxoSmithKline. All
compound stock solutions were prepared in 100% dimethyl sulfoxide
(DMSO), except for tiotropium, ipratropium, and MCh, which were prepared
on the day of experiment in Krebs-Henseleit solution (for vagus nerve
experiments) or distilled water (for imaging), and PGE2, which was dissolved
in ethanol. On the day of the experiment, the compounds were diluted 1:1000
in the appropriate medium to obtain the desired final concentrations.
In vitro vagus nerve experiments. Krebs-Henseleit solution
(NaCl, 118 mmol/L; KCl, 5.9 mmol/L; MgSO4, 1.2 mmol/L; CaCl2,
2.5 mmol/L; NaH2PO4, 1.2 mmol/L; NaHCO3, 25.5 mmol/L; and glucose,
5.6 mmol/L) was made fresh on a daily basis. All salts were purchased from
BDH (Dorset, United Kingdom). On the day of the experiment, stocks were
diluted in Krebs-Henseleit solution to obtain the desired concentration with
0.1% DMSO.
In vitro imaging experiments. Extracellular solution (ECS;
5.4 mmol/L KCl, 136 mmol/L NaCl, 1 mmol/L MgCl2, 2.5 mmol/L CaCl2,
0.33 mmol/L NaH2PO4, 10 mmol/L D-glucose, and 10 mmol/L HEPES;
297 mOsm; pH adjusted to 7.4 with NaOH at 378C) and K50 (50 mmol/L
KCl, 101.4 mmol/L NaCl, 1 mmol/L MgCl2, 2.5 mmol/L CaCl2, 0.33
mmol/L NaH2PO4, 10 mmol/L D-glucose, 10 mmol/L HEPES; 297 mOsm;
pH adjusted to 7.4 with NaOH at 378C) solutions were made fresh daily. All
salts were from BDH and Sigma-Aldrich. Di-8-ANEPPS and Fura2-AM
stocks were prepared as 10-mL aliquots in DMSO and frozen at 2208C. To
load the cells, Di-8-ANEPPS and Fura2-AM aliquots were diluted in 2.5
and 1 mL ECS, respectively. Compound stock solutions were diluted
1:1000 in ECS to the desired final concentrations with 0.1% vehicle
(DMSO or distilled water).
Data analysis and statistics
Inhibition of capsaicin-induced cough was analyzed by using the
nonparametric Kruskal-Wallis test with the Dunn post hoc test, comparing
drug group responses with those of the vehicle control group. Data are
presented as medians 6 interquartile ranges. In the in vivo single-fiber
experiments, inhibition was determined by using a 2-tailed paired Student
t test, comparing responses to agonist (in the same fiber) in the presence and
absence of vehicle/antagonist. Inhibition of agonist-induced vagus nerve
depolarization was analyzed by using the 2-tailed paired Student t test,
comparing responses to agonist (in the same piece of vagus nerve) in the
absence and presence of vehicle/antagonist. For imaging, all responses in
each cell were normalized to the initial response generated by application of
K50 within the same cell. Data were analyzed for ‘‘responding’’ cells only,
which were defined as neurons with a response of 10% or greater of K50.
E7. Hansel TT, Neighbour H, Erin EM, Tan AJ, Tennant RC, Maus JG, et al.
Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in
patients with asthma. Chest 2005;128:1974-9.
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comparing responses to agonist (in the same cell) in the absence and presence
of vehicle/antagonist. Data are presented as means6 SEMs. For all statistical
analyses, P values of less than .05 were considered significant.REFERENCES
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FIG E1. Effect of inhaled tiotropium on MCh-induced Penh change.
Conscious guinea pigs were exposed to an aerosol of vehicle (0.5% ethanol
in saline) or tiotropium (3, 10, or 30 mg/mL) for 10 minutes. Fifty minutes
later, the guinea pigs were placed in the chambers used for cough
experiments and challenged with an aerosol of saline or MCh (0.1 mmol/L).
Penh (a noninvasive surrogate measurement of bronchospasm) was
assessed by using Buxco software. Data are shown as means and SEMs
(n 5 3).
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FIG E2. Effect of tiotropium on inhibition of capsaicin responses on isolated rat and mouse vagal tissue.
The vagal tissue was challenged twice with capsaicin (1 mmol/L) to evoke 2 consecutive control
depolarization responses, and then the tissue was exposed to vehicle or tiotropium (1 nmol/L) for 30
minutes. The tissue was then exposed to capsaicin in the presence of tiotropium. After a washout, the tissue
was rechallenged with capsaicin to confirm tissue viability.A, Inhibition of depolarization induced by capsa-
icin (1 mmol/L) in rat tissue. B, An example trace. C, Depolarization (mV) of mouse isolated vagus nerve tis-
sue induced by capsaicin or capsaicin in the presence of tiotropium and recovery capsaicin response,
indicating that there is no inhibition of the response in mouse tissue. D, An example trace in mouse tissue.
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FIG E3. Effect of MCh on isolated guinea pig trachea and vagal tissue. The MCh cumulative response curve
was performed. A, MCh caused a concentration-related increase in tension (expressed as a percentage of
the average acetylcholine [ACh] response; n 5 4). The vagal tissues were exposed to capsaicin (1 mmol/L)
twice before they were challenged with vehicle or various concentrations of MCh. B, An example vagal
trace. C, Average response over the 4 vagus nerve samples.
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FIG E4. Effect of MCh on primary airway guinea pig ganglion cells. Guinea
pig airway-specific jugular ganglion neurons were challenged with K50 for a
reference response and then exposed to vehicle or random concentrations
of MCh, and calcium levels and changes in membrane voltage were
recorded. A, An example of a calcium recording. B and C, Mean calcium
and voltage changes in cells (7 cells harvested from 3 guinea pigs).
A.U.C., Area under the curve.
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FIG E5. Effect of tiotropium on capsaicin responses in a FLIPR assay (work performed by using GenScript).
HEK293 cells were genetically engineered to overexpress human TRPV1, plated at 20,000 cells per well, and
stimulated with capsaicin. A, Concentration response curve with data expressed as relative fluorescence
units (R.F.U.). B-D, From these data, a submaximal concentration of capsaicin was chosen to profile the
positive control, TRPV1 antagonist JNJ-172030212 (Fig 5, B), tiotropium (Fig 5, C), and glycopyrrolate
(Fig 5, D). Experiments were run in duplicates.
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FIG E6. Effect of tiotropium on capsaicin-induced contraction of guinea pig
trachea. The tracheal tissue was inserted into 10-mL tissue baths with
gassed Krebs-Henseleit solution kept at 378C. The tissue was placed under 1
g of tension and left to settle for 1 hour, with the Krebs-Henseleit solution
being replaced occasionally. The tissue was exposed to a supramaximal
concentration of acetylcholine (1 mmol/L) and then washed; this was
repeated twice more. The tissues were then incubated with vehicle or
tiotropium for 30 minutes, after which cumulative response curves were
measured to MCh (A) or capsaicin (B), and levels of tension in the tissue
were recorded and expressed as a percentage of the average acetylcholine
(ACh) response (n 5 4).
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